España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
GRAIL
GRAL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$22.74
0.58
2.62%
At close: -
$22.74
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
GRAIL (GRAL) Forecast
News
Earnings
GRAIL (GRAL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for GRAIL (NASDAQ:GRAL) Stock
GRAIL Stock (NASDAQ: GRAL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 16, 2024
What's Going On With Illumina Stock On Monday?
Vandana Singh
Wednesday, November 27, 2024
Morgan Stanley Initiates Coverage On GRAIL wi...
Benzinga Newsdesk
Monday, November 18, 2024
GRAIL Announces The First Patient Has Been Te...
Benzinga Newsdesk
Thursday, November 14, 2024
GRAIL 13G Filing Shows Sessa Capital (Master)...
Benzinga Newsdesk
Wednesday, November 13, 2024
GRAIL shares are trading higher after the com...
Benzinga Newsdesk
Tuesday, November 12, 2024
GRAIL Q3 EPS $(3.94) Up From $(28.71) YoY, Sa...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Wednesday, October 23, 2024
GRAIL Presents Early Results From REFLECTION ...
Benzinga Newsdesk
Thursday, October 17, 2024
Guggenheim Initiates Coverage On GRAIL with N...
Benzinga Newsdesk
Monday, October 14, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Tuesday, September 03, 2024
European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine
Vandana Singh
Thursday, August 29, 2024
GRAIL Detailed Findings Of Performance Of Its...
Benzinga Newsdesk
Wednesday, August 14, 2024
GRAIL shares are trading higher. The company ...
Benzinga Newsdesk
Tuesday, August 13, 2024
GRAIL shares are trading higher. The company ...
Benzinga Newsdesk
Trading Halt: Halt status updated at 4:25:00 ...
Benzinga Newsdesk
GRAIL Q2 2024 Revenue $32M, Up 43% YoY
Benzinga Newsdesk
Trading Halt: Halted at 4:00:10 p.m. ET - Tra...
Benzinga Newsdesk
Thursday, July 18, 2024
GRAIL shares are trading lower. The company a...
Benzinga Newsdesk
GRAIL Announces First Participant Enrolled In...
Benzinga Newsdesk
Tuesday, July 16, 2024
Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday?
Piero Cingari
Monday, July 15, 2024
GRAIL Completes PATHFINDER 2 Enrollment And N...
Benzinga Newsdesk
Wednesday, July 10, 2024
Illumina Buys Fluent BioSciences To Gain Stronger Foothold In Single-Cell Analysis
Vandana Singh
Tuesday, June 25, 2024
Illumina Rises on Conclusion of GRAIL Divestment
Zacks
GRAIL Shares Resume Trade
Benzinga Newsdesk
GRAIL Shares Resume Trading
Benzinga Newsdesk
Cancer Test Maker Grail Starts Trading After ...
Benzinga Newsdesk
Once Valued At Around $7B, Cancer Blood Test Developer Grail To Kickstart Trading On NASDAQ
Vandana Singh
Monday, June 24, 2024
GRAIL Will Be Listed And Commence Regular-Way...
Benzinga Newsdesk
GRAIL To Begin Trading On The Nasdaq Stock Ex...
Benzinga Newsdesk
Friday, June 02, 2023
'More Than 400 Grail Patients Incorrectly Tol...
Benzinga Newsdesk
Tuesday, September 13, 2022
CNBC's Final Trades: Volkswagen, Illumina, Goldman Sachs And This Mobility Play
Priya Nigam
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
